Beyond Traditional Medications: Peptides and Supplements in SUD Recovery A growing body of research is exploring how peptides and targeted supplements may support recovery from substance use disorders (SUD) by addressing underlying neurological, psychological, and physiological imbalances
In 2023, semaglutide was the best-selling drug in the United States with nearly $14 billion in sales.1 There are an estimated 100 million obese adults in America, and an additional 37 million who may also be eligible to use medications like GLP-1s to manage chronic conditions
The SAMAS trial (NCT05147896) is also underway, aiming to examine the impact of oral semaglutide on various markers of atherosclerotic cardiovascular disease, including arterial stiffness, carotid intima-media thickness, and endothelial function
Frequent Vitamin Injections B12 excess symptoms
Most athletes notice improvements in recovery, energy, and mental clarity within 24 weeks of consistent daily use
